Descrizione Clinica
Oral hygiene Rofixdol inflammationz dolor spray Rofixdol
ROFIXDOL INFIAMMING AND ONLY 0.16% SPRAY FOR ORAL MUCOSA
active ingredients
100 ml oral mucosa spray contains as an active ingredient: Ketoprofene salt of lysine 0.16 g corresponding to 0.10 g of Ketoprofene. Excipient : Useful p–hydroxybenzoate 0.10 g Propile p–hydroxybenzoate 0.02 g For full list of excipients, see paragraph 6.1.Excellent
Glycerol 85%, xylitol, methyl para-hydroxybenzoate, propile para-hydroxybenzoate, sodium phosphate monobasic, polossamer, aroma mint, purified water.Therapeutic indications
Symptomatic treatment of irritative–inflammatory states also associated with pain of the oropharyngeal cable (e.g. gums, stomatitis, pharyngitis), also as a result of conservative or extractive dentaria therapy.Contraindications
ROFIXDOL INFIAMMATION AND DOLORE 0.16% oral mucosa spray should not be administered in case of hypersensitivity to the active ingredient, to other nonsteroidal anti-inflammatory drugs (NSAID) or to any of the excipients, to patients in which substances with analogous mechanism of action (e.g. acetylsalicylic acid or other NSAIDs) cause asthma, bronchospasm, acute stroke.Population
1–2 sprays up to 3 times a day, directed directly to the interested part. Each spray dispenses about 0.2 ml of solution, equivalent to 0.32 mg of active ingredient.Conservation
No special education.Warnings
The use, especially if prolonged by topical medicines, could give rise to awareness-raising phenomena, in which case it is necessary to suspend the treatment and to take appropriate therapeutic measures. Important information about some excipients: The drug contains para-hydroxybenzoates, which can cause allergic reactions (also delayed).Interactions
At present there are no known interactions with other drugs: interactions that can also be excluded considering the way of administration and the dosage of drug administered.Effects
Local undesirable effects as a result of topical administration on the oral mucosa of solution of ketoprofen salt lisin are extremely rare and consist of irritative or allergic phenomena (angiourotic edema) especially in subjects with hypersensitivity to NSAIDs. However, systemic side effects have not emerged considering the route of administration and the dosage of the drug administered.Overdosing
To date there are no known cases of overdose even considering the amount of active ingredient that would not make an accidental overdose possible.As with other non-steroidal anti-inflammatory drugs, the product should not be used in case of established or presumed pregnancy and during breastfeeding.
Source: Farmadati
